These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8090582)

  • 1. Immunocytochemical demonstration of melanotransferrin (p97) in thyroid tumors of follicular cell origin.
    Barresi G; Tuccari G
    Pathology; 1994 Apr; 26(2):127-9. PubMed ID: 8090582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue polypeptide antigen in thyroid tumours of follicular cell origin: an immunohistochemical re-evaluation for diagnostic purposes.
    Tuccari G; Barresi G
    Histopathology; 1990 Apr; 16(4):377-81. PubMed ID: 2361653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of leu 7 and PCNA expression in thyroid neoplasms.
    Fucich LF; Freeman SM; Marrogi AJ
    Biotech Histochem; 1996 Nov; 71(6):298-303. PubMed ID: 8957557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.
    Ghali VS; Jimenez EJ; Garcia RL
    Hum Pathol; 1992 Jan; 23(1):21-5. PubMed ID: 1371984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercellular adhesion molecule-1 (ICAM-1) immunoreactivity in well-differentiated thyroid papillary carcinomas.
    Tanda F; Cossu A; Bosincu L; Manca A; Ibba M; Massarelli G
    Mod Pathol; 1996 Jan; 9(1):53-6. PubMed ID: 8821957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical localisation of tumor necrosis factor alpha in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders.
    Kayser L; Broholm H; Francis D; Perrild H; Olsen BE; Bendtzen K; Høyer PE
    Autoimmunity; 1996; 23(2):91-7. PubMed ID: 8871764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
    Xu YJ
    Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma.
    Tomoda C; Kushima R; Takeuti E; Mukaisho K; Hattori T; Kitano H
    Thyroid; 2003 Mar; 13(3):291-5. PubMed ID: 12729479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas.
    Tuccari G; Barresi G
    Histopathology; 1987 Jul; 11(7):723-31. PubMed ID: 3623436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
    Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2005; 25(1A):179-82. PubMed ID: 15816536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma.
    Schelfhout LJ; Van Muijen GN; Fleuren GJ
    Am J Clin Pathol; 1989 Nov; 92(5):654-8. PubMed ID: 2479256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].
    Guyétant S; Michalak S; Valo I; Saint-André JP
    Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.
    Sigstad E; Paus E; Bjøro T; Berner A; Grøholt KK; Jørgensen LH; Sobrinho-Simões M; Holm R; Warren DJ
    Mod Pathol; 2012 Apr; 25(4):537-47. PubMed ID: 22157935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
    Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
    Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1.
    Katoh R; Bray CE; Suzuki K; Komiyama A; Hemmi A; Kawaoi A; Oyama T; Sugai T; Sasou S
    Hum Pathol; 1995 Feb; 26(2):139-46. PubMed ID: 7860043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological aspects of cancers arising from thyroid follicular cells.
    Baker JR; Fosso CK
    Endocr Rev; 1993 Dec; 14(6):729-46. PubMed ID: 8119235
    [No Abstract]   [Full Text] [Related]  

  • 19. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.
    Raphael SJ; McKeown-Eyssen G; Asa SL
    Mod Pathol; 1994 Apr; 7(3):295-300. PubMed ID: 7520169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
    Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
    Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.